• This will change your mind about Biohacking and Psychedelics

  • Oct 25 2021
  • Length: 1 hr
  • Podcast
This will change your mind about Biohacking and Psychedelics cover art

This will change your mind about Biohacking and Psychedelics

Listen for free

View show details

  • Summary

  • In this week's Dealmaker Show Interview, Oren will talk to Doug Drysdale on Biohacking and Psychedelics. Doug Drysdale has chaired the board of directors of a NASDAQ-listed company and as a CEO for the past 13 years has built and turned around four pharmaceutical companies. During Doug’s 30 years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, and has raised $4 billion of both public and private capital. Previously, Doug served as Head of M&A at Actavis Group, leading 15 corporate acquisitions across three continents, between 2004 and 2008. Over this period, Doug raised approximately $3 billion of capital and managed lending syndicates including over 25 banks, to fund the company’s growth. Actavis was sold to Watson Pharmaceuticals in 2012 for EUR4.25 billion. Doug holds a bachelor’s degree in Microbial and Molecular Biology from the University of East Anglia in the U.K. and was recognized as Entrepreneur of the Year by Ernst and Young, in 2012.
    Show More Show Less
Leadership Economics
Show More Show Less

What listeners say about This will change your mind about Biohacking and Psychedelics

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.